Opexa Therapeutics Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $7.01M

Opexa Therapeutics General Information

Description

Provider and developer of patient-specific cellular therapies intended for the treatment of autoimmune diseases. The company's personalized cellular immunotherapy treatment is in late stage clinical development targeting both Secondary Progressive and Relapsing Remitting MS, aligning the interests of patients, employees and shareholders.

Contact Information

Formerly Known As
Sportan United Industries, PharmaFrontiers
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 2635 Technology Forest Boulevard
  • The Woodlands, TX 77381
  • United States
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 2635 Technology Forest Boulevard
  • The Woodlands, TX 77381
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Opexa Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Merger/Acquisition 19-Sep-2017 $7.01M Completed Profitable
9. 2PO 07-Aug-2013 Completed Profitable
8. Debt - General 15-Feb-2013 Completed Profitable
7. PIPE 16-Nov-2012 Completed Profitable
6. PIPE Completed Profitable
5. Convertible Debt 01-May-2009 Completed Profitable
4. PIPE 13-Apr-2008 Completed Profitable
3. Accelerator/Incubator 01-Jan-2008 Completed Profitable
2. IPO 14-Apr-2004 Completed Profitable
1. Early Stage VC 01-Feb-2001 Completed Profitable
To view Opexa Therapeutics’s complete valuation and funding history, request access »

Opexa Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider and developer of patient-specific cellular therapies intended for the treatment of autoimmune diseases. The com
Biotechnology
The Woodlands, TX

Gaithersburg, MD
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Opexa Therapeutics Competitors (57)

One of Opexa Therapeutics’s 57 competitors is NexImmune, a Formerly VC-backed company based in Gaithersburg, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NexImmune Formerly VC-backed Gaithersburg, MD
Intellia Therapeutics Formerly VC-backed Cambridge, MA
Sorrento Therapeutics Formerly VC-backed San Diego, CA
Kite Pharma Formerly VC-backed Santa Monica, CA
MediGene Formerly VC-backed Planegg, Germany
You’re viewing 5 of 57 competitors. Get the full list »

Opexa Therapeutics Patents

Opexa Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2759572-A1 Isolation and identification of t cells Inactive 08-Aug-2002
AU-2003258090-B2 Isolation and identification of t cells Inactive 08-Aug-2002
AU-2003258090-A1 Isolation and identification of t cells Active 08-Aug-2002
CA-2492848-A1 Isolation and identification of t cells Active 08-Aug-2002
ES-2545736-T3 Isolation and identification of t cells Inactive 08-Aug-2002 G01N33/53
To view Opexa Therapeutics’s complete patent history, request access »

Opexa Therapeutics Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
BCM Ventures Venture Capital Minority
Diker Management Hedge Fund Minority
Houston Technology Center Accelerator/Incubator Minority
Lehman Brothers Other Private Equity Minority
Lincoln Park Capital Asset Manager Minority
You’re viewing 5 of 6 investors. Get the full list »

Opexa Therapeutics Acquisitions (1)

Opexa Therapeutics’s most recent deal was a Reverse Merger with Acer Therapeutics. The deal was made on 19-Sep-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Acer Therapeutics 19-Sep-2017 Reverse Merger Drug Discovery
To view Opexa Therapeutics’s complete acquisitions history, request access »

Opexa Therapeutics FAQs

  • When was Opexa Therapeutics founded?

    Opexa Therapeutics was founded in 2001.

  • Where is Opexa Therapeutics headquartered?

    Opexa Therapeutics is headquartered in The Woodlands, TX.

  • What industry is Opexa Therapeutics in?

    Opexa Therapeutics’s primary industry is Biotechnology.

  • Is Opexa Therapeutics a private or public company?

    Opexa Therapeutics is a Private company.

  • What is the current valuation of Opexa Therapeutics?

    The current valuation of Opexa Therapeutics is .

  • What is Opexa Therapeutics’s current revenue?

    The current revenue for Opexa Therapeutics is .

  • How much funding has Opexa Therapeutics raised over time?

    Opexa Therapeutics has raised $22.9M.

  • Who are Opexa Therapeutics’s investors?

    BCM Ventures, Diker Management, Houston Technology Center, Lehman Brothers, and Lincoln Park Capital are 5 of 6 investors who have invested in Opexa Therapeutics.

  • Who are Opexa Therapeutics’s competitors?

    NexImmune, Intellia Therapeutics, Sorrento Therapeutics, Kite Pharma, and MediGene are some of the 57 competitors of Opexa Therapeutics.

  • When was Opexa Therapeutics acquired?

    Opexa Therapeutics was acquired on 19-Sep-2017.

  • Who acquired Opexa Therapeutics?

    Opexa Therapeutics was acquired by Acer Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »